Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
3.042
Zitationen
12
Autoren
2003
Jahr
Abstract
Treatment with pemetrexed plus cisplatin and vitamin supplementation resulted in superior survival time, time to progression, and response rates compared with treatment with cisplatin alone in patients with malignant pleural mesothelioma. Addition of folic acid and vitamin B12 significantly reduced toxicity without adversely affecting survival time.
Ähnliche Arbeiten
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
1995 · 8.763 Zit.
Cellular and molecular mechanisms of fibrosis
2007 · 4.393 Zit.
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
2013 · 4.192 Zit.
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 · 3.384 Zit.
IARC monographs on the evaluation of carcinogenic risks to humans
1989 · 2.895 Zit.